Abstract
A patient with a phaeochromocytoma and severe left ventricular heart failure caused by a catecholamine-induced cardiomyopathy is described. The clinical signs of congestive heart failure resolved rapidly on treatment with captopril and myocardial performance became normal within two weeks of medical treatment with captopril for one week and with captopril in combination with phenoxybenzamine for another week.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dzau V. J. Cardiac renin-angiotensin system. Molecular and functional aspects. Am J Med. 1988 Mar 11;84(3A):22–27. doi: 10.1016/0002-9343(88)90201-x. [DOI] [PubMed] [Google Scholar]
- Engelman K. Phaeochromocytoma. Clin Endocrinol Metab. 1977 Nov;6(3):769–797. doi: 10.1016/s0300-595x(77)80079-0. [DOI] [PubMed] [Google Scholar]
- Hu Z. W., Billingham M., Tuck M., Hoffman B. B. Captopril improves hypertension and cardiomyopathy in rats with pheochromocytoma. Hypertension. 1990 Feb;15(2):210–215. doi: 10.1161/01.hyp.15.2.210. [DOI] [PubMed] [Google Scholar]
- Imperato-McGinley J., Gautier T., Ehlers K., Zullo M. A., Goldstein D. S., Vaughan E. D., Jr Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med. 1987 Mar 26;316(13):793–797. doi: 10.1056/NEJM198703263161307. [DOI] [PubMed] [Google Scholar]
- Rosenbaum J. S., Ginsburg R., Billingham M. E., Hoffman B. B. Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma. J Pharmacol Exp Ther. 1987 Apr;241(1):354–360. [PubMed] [Google Scholar]
- Sardesai S. H., Mourant A. J., Sivathandon Y., Farrow R., Gibbons D. O. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990 Apr;63(4):234–237. doi: 10.1136/hrt.63.4.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singal P. K., Kapur N., Dhillon K. S., Beamish R. E., Dhalla N. S. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol. 1982 Nov;60(11):1390–1397. doi: 10.1139/y82-207. [DOI] [PubMed] [Google Scholar]
- Sloand E. M., Thompson B. T. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984 Jan;144(1):173–174. [PubMed] [Google Scholar]
- Stenström G., Holmberg S. Cardiomyopathy in phaeochromocytoma: report of a case with a 16-year follow-up after surgery and review of the literature. Eur Heart J. 1985 Jun;6(6):539–544. doi: 10.1093/oxfordjournals.eurheartj.a061900. [DOI] [PubMed] [Google Scholar]
- Van Vliet P. D., Burchell H. B., Titus J. L. Focal myocarditis associated with pheochromocytoma. N Engl J Med. 1966 May 19;274(20):1102–1108. doi: 10.1056/NEJM196605192742002. [DOI] [PubMed] [Google Scholar]
- Wark J. D., Larkins R. G. Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. Br Med J. 1978 May 27;1(6124):1395–1396. doi: 10.1136/bmj.1.6124.1395-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood R., Commerford P. J., Rose A. G., Tooke A. Reversible catecholamine-induced cardiomyopathy. Am Heart J. 1991 Feb;121(2 Pt 1):610–613. doi: 10.1016/0002-8703(91)90740-9. [DOI] [PubMed] [Google Scholar]